{
    "2018-02-07": [
        [
            {
                "time": "",
                "original_text": "[看好评级]化学制药行业周报：继续围绕一致性评价和创新药等主线进行布局",
                "features": {
                    "keywords": [
                        "化学制药",
                        "一致性评价",
                        "创新药",
                        "布局"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "化学制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：继续围绕一致性评价和创新药等主线进行布局 荐6股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "一致性评价",
                        "创新药",
                        "布局",
                        "荐股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[看好评级]医药生物行业周报：一致性评价执行政策落地加速",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一致性评价",
                        "政策",
                        "落地加速"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]2018年2月医药行业投资策略：关注年报、一季报行情",
                "features": {
                    "keywords": [
                        "医药",
                        "投资策略",
                        "年报",
                        "一季报",
                        "行情"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "融资客最看好个股一览",
                "features": {
                    "keywords": [
                        "融资客",
                        "看好",
                        "个股"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}